Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2025-12-25 @ 4:58 PM
NCT ID: NCT01009203
Term: Hypertriglyceridemia (High triglyceride levels)
Organ System: Investigations
Assessment Type: NON_SYSTEMATIC_ASSESSMENT
Source Vocabulary: CTCAE (3.0)
Notes: None
Study: NCT01009203
Study Brief: Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 2 2 12 View